Incyte (INCY)

86.92 -1.78 (2.01%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/19 *Est.)

Latest Headlines

Form 4 INCYTE CORP For: Jun 17 Filed by: SWAIN PAULA J June 18, 2019 5:27 PM - SEC Filing Incyte (INCY) option implied volatility increases with share price on conference call June 17, 2019 10:04 AM - StreetInsider Incyte (INCY) Weekend Data Points To $1B Peak Sales For Ruxolitinib - Stifel June 17, 2019 8:56 AM - StreetInsider Incyte (INCY) Reports Positive Results from Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo June 17, 2019 5:43 AM - StreetInsider Incyte (INCY) option implied volatility low into conference call to discuss portfolio June 17, 2019 4:54 AM - StreetInsider Incyte Announces Positive Results from a Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo June 15, 2019 3:25 AM - BizWire Form 4 INCYTE CORP For: Jun 06 Filed by: BAKER FELIX June 7, 2019 6:42 PM - SEC Filing Form SC 13D/A INCYTE CORP Filed by: BAKER BROS. ADVISORS LP June 7, 2019 5:14 PM - SEC Filing Incyte (INCY) Reports First Patient Treated in Phase 3 Clinical Trial of Pemigatinib as First-Line Therapy for Cholangiocarcinoma June 4, 2019 7:31 AM - StreetInsider Incyte Announces First Patient Treated in Phase 3 Clinical Trial of Pemigatinib as a First-Line Therapy for Cholangiocarcinoma June 4, 2019 7:30 AM - BizWire New Data from GEOMETRY mono-1 Study Show Clinically Meaningful Results in Patients with Non-Small Cell Lung Cancer with MET exon-14 Skipping Mutation Treated with Capmatinib June 3, 2019 1:45 AM - BizWire BriaCell’s Novel Technology and Clinical Data Published at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting May 28, 2019 6:30 AM - Globe NewsWire Incyte (INCY) Confirms FDA Approval of Jakafi for GVHD May 24, 2019 1:45 PM - StreetInsider FDA Approves Jakafi® (ruxolitinib) for the Treatment of Patients with Acute Graft-Versus-Host Disease May 24, 2019 1:43 PM - BizWire Incyte (INCY) gains new FDA approval of Jakafi May 24, 2019 1:34 PM - StreetInsider Incyte to Present at Upcoming Investor Conference May 23, 2019 8:00 AM - BizWire Credit Suisse Starts Incyte (INCY) at Neutral May 20, 2019 4:26 PM - StreetInsider Data from Incyte’s Inflammation and Autoimmunity Portfolio to be Featured at the 24th World Congress of Dermatology May 20, 2019 7:30 AM - BizWire Incyte (INCY) Announces Abstracts Accepted for Presentation at ASCO and EHA May 16, 2019 12:01 PM - StreetInsider Incyte Announces Abstracts Accepted for Presentation at the 2019 ASCO Annual Meeting and the 24th Congress of EHA May 16, 2019 12:00 PM - BizWire BriaCell Approves New Board of Directors and Chairman at Annual and Special Meeting of Shareholders May 13, 2019 6:30 AM - Globe NewsWire Form 4 INCYTE CORP For: May 09 Filed by: Iyengar Vijay K May 10, 2019 4:43 PM - SEC Filing Merus N.V. (MRUS) Reports First Patient Treated in Phase 1 Clinical Trial of MCLA-145 for Advanced Solid Tumors May 9, 2019 8:18 AM - StreetInsider Merus Announces First Patient Treated in Phase 1 Clinical Trial of MCLA-145 for Advanced Solid Tumors May 9, 2019 8:02 AM - StreetInsider Merus Announces First Patient Treated in Phase 1 Clinical Trial of MCLA-145 for Advanced Solid Tumors May 9, 2019 8:00 AM - Globe NewsWire Barclays Downgrades Incyte (INCY) to Equalweight May 3, 2019 4:42 AM - StreetInsider Incyte to Present at Upcoming Investor Conferences May 2, 2019 8:00 AM - BizWire Form 4 INCYTE CORP For: Apr 26 Filed by: BAKER FELIX April 30, 2019 6:03 PM - SEC Filing Form S-8 INCYTE CORP April 30, 2019 4:48 PM - SEC Filing Form 8-K INCYTE CORP For: Apr 26 April 30, 2019 4:33 PM - SEC Filing Form 10-Q INCYTE CORP For: Mar 31 April 30, 2019 4:16 PM - SEC Filing Form 8-K INCYTE CORP For: Apr 30 April 30, 2019 7:24 AM - SEC Filing Incyte (INCY) Tops Q1 EPS by 22c, Revenues Beat; Offers FY19 Revenue Guidance Below Consensus April 30, 2019 7:12 AM - StreetInsider Incyte Reports 2019 First Quarter Financial Results and Provides Updates on Key Clinical Programs April 30, 2019 7:00 AM - BizWire Form 4 INCYTE CORP For: Apr 26 Filed by: FRIEDMAN PAUL A April 29, 2019 5:21 PM - SEC Filing Form 4 INCYTE CORP For: Apr 26 Filed by: FOUSE JACQUALYN A April 29, 2019 5:13 PM - SEC Filing Form 4 INCYTE CORP For: Apr 26 Filed by: DIXON WENDY L April 29, 2019 5:09 PM - SEC Filing Form 4 INCYTE CORP For: Apr 26 Filed by: Clancy Paul J April 29, 2019 5:06 PM - SEC Filing Form 4 INCYTE CORP For: Apr 26 Filed by: BROOKE PAUL A April 29, 2019 4:59 PM - SEC Filing Form 4 INCYTE CORP For: Apr 26 Filed by: BIENAIME JEAN JACQUES April 29, 2019 4:50 PM - SEC Filing Form DEFA14A INCYTE CORP April 22, 2019 5:21 PM - SEC Filing Incyte (INCY) Pipeline Remains Under Appreciated - Cowen April 22, 2019 8:37 AM - StreetInsider Form 4 INCYTE CORP For: Apr 09 Filed by: Pasquale Maria E April 11, 2019 5:04 PM - SEC Filing Incyte to Report First Quarter Financial Results April 11, 2019 8:00 AM - BizWire Stifel Starts Incyte (INCY) at Hold April 10, 2019 4:14 PM - StreetInsider Concert Pharma (CNCE) Patent Ruled Invalid After Incyte (INCY) Review Challenge - Bloomberg April 8, 2019 2:05 PM - StreetInsider Merus Announces Financial Results for the Full Year 2018 and Provides Business Update April 3, 2019 4:00 PM - StreetInsider RBC Capital Downgrades Incyte (INCY) to Sector Perform April 3, 2019 6:24 AM - StreetInsider Form 4 INCYTE CORP For: Mar 29 Filed by: BAKER FELIX April 2, 2019 5:29 PM - SEC Filing Form 4 INCYTE CORP For: Mar 29 Filed by: Clancy Paul J April 2, 2019 5:17 PM - SEC Filing Form 4 INCYTE CORP For: Apr 01 Filed by: SWAIN PAULA J April 2, 2019 5:00 PM - SEC Filing Form 4 INCYTE CORP For: Mar 29 Filed by: FOUSE JACQUALYN A April 2, 2019 4:57 PM - SEC Filing Form 4 INCYTE CORP For: Mar 29 Filed by: DIXON WENDY L April 2, 2019 4:54 PM - SEC Filing Form 4 INCYTE CORP For: Mar 29 Filed by: BROOKE PAUL A April 2, 2019 4:41 PM - SEC Filing Form 4 INCYTE CORP For: Mar 29 Filed by: BIENAIME JEAN JACQUES April 2, 2019 4:39 PM - SEC Filing BriaCell Announces Clinical Trial Collaboration Agreement with Incyte (INCY) April 2, 2019 3:01 PM - StreetInsider BriaCell Announces Clinical Trial Collaboration Agreement with Incyte April 2, 2019 2:58 PM - Globe NewsWire Form PX14A6G INCYTE CORP Filed by: FLAHERTY DUNDAS I April 1, 2019 1:37 PM - SEC Filing Merus N.V. (MRUS), Incyte (INCY) Present MCLA-145 Program Preclinical Data at AACR April 1, 2019 7:13 AM - StreetInsider Merus and Incyte Present MCLA-145 Program Preclinical Data at the AACR Annual Meeting 2019 April 1, 2019 7:00 AM - Globe NewsWire Merus and Incyte Present MCLA-145 Program Preclinical Data at the AACR Annual Meeting 2019 April 1, 2019 7:00 AM - StreetInsider Full Article List